MyAverix Finance
SA · Healthcare
Dr. Reddy's Laboratories Limited (R1DY34)
Drug Manufacturers - Specialty & Generic
Dr. Reddy's Laboratories Limited (R1DY34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $60.19B, P/E ratio is 18.76, net margin is 16.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R1DY34
Dr. Reddy's Laboratories Limited (R1DY34) — FAQ
What is Dr. Reddy's Laboratories Limited's market cap?
Dr. Reddy's Laboratories Limited (R1DY34) has a reported market cap of $60.19B (data as of 2026-03-29).
What is R1DY34's P/E ratio?
The price-to-earnings (P/E) ratio for Dr. Reddy's Laboratories Limited (R1DY34) is 18.76 (data as of 2026-03-29).
Does Dr. Reddy's Laboratories Limited pay a dividend?
Dividend yield is not available in the current snapshot for Dr. Reddy's Laboratories Limited (R1DY34). Check the MyAverix Finance app for the latest dividend data.
What sector is Dr. Reddy's Laboratories Limited in?
Dr. Reddy's Laboratories Limited (R1DY34) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is R1DY34 listed on?
R1DY34 is listed on SA.
What is Dr. Reddy's Laboratories Limited's net margin?
Dr. Reddy's Laboratories Limited (R1DY34) reports a net margin of 16.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.